Antibiotic B 14437 (base)NSC65346SauzivamycinSKI 270134-amino-7-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carboxamideB 90912MLS000517268MLS002703016Antibiotic B-14437SMR000127424B-144374-amino-7-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carboxamide;hydrate
名称をさらに表示
4-アミノ-7-β-D-リボフラノシル-7H-ピロロ[2,3-d]ピリミジン-5-カルボアミド抗生物質BA-909124-アミノ-7-β-D-リボフラノシル-7H-ピロロ[2,3-d]ピリミジン-5-カルボキサミド抗生物質B-144374-アミノ-7-(β-D-リボフラノシル)-7H-ピロロ[2,3-d]ピリミジン-5-カルボアミドサンギバマイシンb90912BA-90912ski27013NSC-65346morimycinSANGIVAMYCINantibioticb-14437Antibiotic BA-90912Sangivamycin, 10 mM in DMSO
定義ChEBI: A nucleoside analogue that is adenosine in which the nitrogen at position 7 is replaced by a carbamoyl-substituted carbon. It is a potent inhibitor of protein kinase C.